For ERCC2 rs1799793, our meta-analysis showed that compared with G allele, A allele was associated with an increased risk of CRC (A vs. G: OR = 1.163, 95% CI = 1.021–1.325, p = 0.023) (Figure 4). This evidence concerns the gene ERCC2 and colorectal carcinoma.